About this trial
This randomized, double-blind, placebo-controlled clinical trial aims to evaluate whether single-dose amoxicillin prophylaxis administered prior to simple tooth extraction reduces postoperative infection rates in immunosuppressed patients with autoimmune rheumatic diseases (ARDs).
Although antibiotic prophylaxis is not recommended for healthy individuals undergoing simple extractions, immunosuppressed ARD patients frequently receive antibiotics despite limited evidence supporting this practice.
Secondary objectives include assessing infection severity, postoperative complications, and the impact of ARD diagnosis and immunosuppressive treatment on infection risk.
Eligibility criteria
Qualifiers
Age ≥18 years
Confirmed diagnosis of an ARD: SLE, RA, JIA, AS, PsA, IIM, systemic vasculitis, primary Sjögren's syndrome, or SSc
Under immunosuppressive or biologic therapy ≥3 months
Indication for simple extraction of tooth with chronic odontogenic focus
Disqualifiers
Individuals who do not agree to participate in the study will be excluded.
Patients who require more technically complex extractions, such as impacted or impacted third molars.
Patients with local and systemic changes that require more extensive antibiotic coverage, such as cases with clinical signs of acute infections, anticoagulated patients, heart patients, patients who have undergone radiotherapy or are undergoing treatment for neoplasms.
Patients allergic to amoxicillin.
Trial design
Treatments tested in this trial
- Amoxicillin
- Placebo
Treatment groups
Locations
Sponsors and collaborators
University of Sao Paulo General Hospital
Lead sponsor
Fundação de Amparo à Pesquisa do Estado de São Paulo
Collaborator